NCT02543645: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer |
|
|
| Terminated | 1 | 18 | US | Combination of Varlilumab and Atezolizumab | Celldex Therapeutics, Genentech, Inc. | Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Neoplasms by Histologic Type, Neoplasms, Clear-cell Metastatic Renal Cell Carcinoma, Melanoma, Triple Negative Breast Cancer, Bladder Cancer, Head and Neck Cancer, Non-small Cell Lung Cancer | 04/17 | 05/17 | | |
NCT02298153: A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110) |
|
|
| Terminated | 1 | 29 | US | atezolizumab, MPDL3280A, epacadostat, INCB024360 | Incyte Corporation, Hoffmann-La Roche, Genentech, Inc. | NSCLC (Non-small Cell Lung Carcinoma), UC (Urothelial Cancer) | 11/17 | 11/17 | | |
NCT02463994: A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC |
|
|
| Completed | 1 | 12 | US | MPDL3280A, Hypofractionated Radiotherapy | University of Michigan Rogel Cancer Center, University of Washington | Non-small Cell Lung Cancer | 11/18 | 11/18 | | |
